Why a veterinary tranquilizer is now a major threat in the human drug supply

Why a veterinary tranquilizer is now a major threat in the human drug supply
Image: Intellect (generated)

In short: Xylazine, a powerful non-opioid sedative never approved for human use, is increasingly contaminating the illegal drug supply. Often mixed with fentanyl to increase street value, it slows breathing and heart rate while causing severe, necrotic skin wounds. Because it is not an opioid, standard overdose reversals like naloxone cannot stop it.

Originally synthesized in 1962 in West Germany as an antihypertensive, xylazine was quickly abandoned for human use after clinical trials revealed it caused severe central nervous system depression. By the late 1960s, it had been repurposed as a veterinary sedative and muscle relaxant for large animals. Today, it is widely used in veterinary medicine, though it is increasingly being replaced in small animal practice by more selective alpha-2 adrenergic receptor agonists like medetomidine.

The drug's recent emergence in the North American illicit market has created a public health crisis. It is frequently used as a cutting agent for heroin, cocaine, and fentanyl to prolong psychoactive effects and increase weight. In 2022, the DEA reported that approximately 23% of seized fentanyl powder and 7% of seized fentanyl pills contained xylazine. This adulteration is particularly dangerous because xylazine induces peripheral vasoconstriction, which is believed to contribute to the development of necrotic, treatment-resistant skin ulcers that can lead to amputation if left untreated.

The combination of fentanyl and xylazine poses unique clinical challenges. While naloxone is essential for reversing opioid-driven respiratory depression, it has no effect on xylazine. Consequently, first responders are encouraged to provide rescue breaths, as xylazine specifically slows breathing. Recent kinome research on human neuronal cells suggests that the combination of these drugs uniquely alters kinase signaling pathways, potentially explaining why the mixture is more lethal than either substance alone. As of 2024, the White House has implemented a national response plan to address this emerging threat, yet clinicians remain hampered by a lack of rapid screening infrastructure and standardized management guidelines.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-xylazine.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…